Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Biocardia Inc (BCDA)

2.34   -0.07 (-2.9%) 08-14 16:00
Open: 2.4 Pre. Close: 2.41
High: 2.4 Low: 2.2602
Volume: 97,776 Market Cap: 29M
BioCardia, Inc., a clinical-stage regenerative medicine company, develops therapeutics for cardiovascular diseases. Its lead therapeutic candidate is the CardiAMP Cell Therapy System for the treatment of heart failure and chronic myocardial ischemia. The company is also developing CardiALLO Cell Therapy System, an investigational culture expanded bone marrow derived from mesenchymal cell therapy, which is in Phase I/II trial for the treatment of ischemic systolic heart failure. In addition, it offers the Helix biotherapeutic delivery system; and Morph vascular access product line, which provides catheter products. BioCardia, Inc. is based in San Carlos, California.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 2.404 - 2.42 2.42 - 2.433
Low: 2.218 - 2.24 2.24 - 2.256
Close: 2.309 - 2.339 2.339 - 2.363

Technical analysis

as of: 2020-08-14 4:27:42 PM
Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 3.11     One year: 3.41
Support: Support1: 2.25    Support2: 1.87
Resistance: Resistance1: 2.66    Resistance2: 2.92
Pivot: 2.56
Moving Average: MA(5): 2.52     MA(20): 2.58
MA(100): 3.23     MA(250): 3.82
MACD: MACD(12,26): -0.05     Signal(9): -0.04
Stochastic oscillator: %K(14,3): 16.21     %D(3): 28.60
RSI: RSI(14): 40.00
52-week: High: 7.25  Low: 2.01  Change(%): -52.2
Average Vol(K): 3-Month: 23088  10-Days: 20869

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
BCDA has closed above bottom band by 7.7%. Bollinger Bands are 59.7% narrower than normal. The narrow width of the bands suggests low volatility as compared to BCDA's normal range. The bands have been in this narrow range for 28 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Fri, 14 Aug 2020
Is BioCardia Inc (BCDA) a Winner in the Biotechnology Industry? - InvestorsObserver

Thu, 13 Aug 2020
Bsquare Reports Second Quarter 2020 Financial Results - Yahoo Finance

Thu, 13 Aug 2020
Outlook on technical trends for markets, economic expectations - Yahoo Money

Thu, 13 Aug 2020
Is BioCardia Inc (BCDA) Stock About to Get Hot Thursday? - InvestorsObserver

Thu, 13 Aug 2020
BioCardia Reports Second Quarter 2020 Financial Results and Business Highlights - GlobeNewswire

Wed, 12 Aug 2020
Analyst Rating: Will BioCardia Inc (BCDA) Stock Outperform the Market? - InvestorsObserver

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NasdaqCM
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 12
Shares Float (M) 4
% Held by Insiders 76.90
% Held by Institutions 3.06
Shares Short (K) 59
Shares Short P. Month (K) 30

Stock Financials

EPS -2.486
EPS Est This Year
EPS Est Next Year
Book Value (p.s.) -0.190
Profit Margin
Operating Margin -2844.93
Return on Assets (ttm) -198.3
Return on Equity (ttm)
Qtrly Rev. Growth -82.4
Gross Profit (p.s.) -0.666
Sales Per Share 0.043
EBITDA (p.s.) -1.220
Qtrly Earnings Growth
Operating Cash Flow (M) -10
Levered Free Cash Flow (M) -5

Stock Valuations

PE Ratio -0.94
PEG Ratio
Price to Book value -12.32
Price to Sales 54.19
Price to Cash Flow -2.89

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.